9-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency Syndrome
Authors: MICHAEL C. BACH
Journal: Annals of Internal Medicine (1985)

Brief Reports1 September 19859-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency SyndromeMICHAEL C. BACH, M.D., SANDRA P. BAGWELL, M.D., NANCY P. KNAPP, M.D., KENT M. DAVIS, M.D., PETER S. HEDSTROM, M.D.MICHAEL C. BACH, M.D.Search for more papers by this author, SANDRA P. BAGWELL, M.D.Search for more papers by this author, NANCY P. KNAPP, M.D.Search for more papers by this author, KENT M. DAVIS, M.D.Search for more papers by this author, PETER S. HEDSTROM, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-103-3-381 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDisseminated cytomegalovirus infection is a major cause of mortality in patients with the acquired immuno-deficiency syndrome (1) as well as in other immunosuppressed patients including bone marrow transplant recipients (2). We have had recent positive results with the use of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG), a new nucleoside antiviral agent, in halting progressive hemorrhagic retinitis and symptomatic pneumonitis due to cytomegalovirus. We report our experience with DHPG in three patients with the acquired immunodeficiency syndrome.Patient 1:A 31-year-old man was diagnosed as having the acquired immunodeficiency syndrome in November 1983 when he developedPneumocystis cariniipneumonia. In June 1984 he developed a...References1. QUINNANMASURROOK GHA. Herpesvirus infections in the acquired immunodeficiency syndrome. JAMA. 1984;252:72-7. CrossrefMedlineGoogle Scholar2. MEYERSSPENCERWATTS JHJ. Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med. 1975;82:181-8. LinkGoogle Scholar3. RASMUSSENCHENMULLENAXMERIGAN LPJT. Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons. Antimicrob Agents Chemother. 1984;26:441-5. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Maine Medical Center Portland Maine PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHIV-Associated InfectionsThe history of cytomegalovirus and its diseasesRetinal Disease in HIV-infected PatientsCNS Manifestations of Cytomegalovirus InfectionsChemotherapeuticsEffect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivoDiseases of the RetinaOcular complications of the acquired immunodeficiency syndromeSystemic antiviral drugs used in ophthalmologyAcquired Immunodeficiency SyndromeA Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDSAlan G. Palestine, MD, Michael A. Polis, MD, Marc D. De Smet, MD, Barbara F. Baird, BSN, Judith Falloon, MD, Joseph A. Kovacs, MD, Richard T. Davey, MD, John J. Zurlo, MD, Kathryn M. Zunich, MD, Matthew Davis, MD, Larry Hubbard, Rosemary Brothers, Frederick L. Ferris, MD, Emily Chew, MD, Janet L. Davis, MD, Benjamin I. Rubin, MD, Susan D. Mellow, RN, Julia A. Metcalf, BS, Jody Manischewitz, MS, James R. Minor, PharmD, Robert B. Nussenblatt, MD, Henry Masur, MD, H. Clifford Lane, MDPharyngeal Ulceration in AIDS Patients Secondary to Cytomegalovirus InfectionOptimizing recovery of cytomegalovirus in the shell vial culture procedureNovel Pharmacological Strategies in the Treatment of Life-Threatening Cytomegalovirus Infections.Prevention of Foscarnet NephrotoxicityG. Deray, MD, C. Katlama, MD, E. Dohin, MDAntiviral effect of antileukemic drugs N4-Behenoyl-1-β-D-Arabinofuranosylcytosine (BH-AC) and 2,2′-Anhydro-1-β-D-Arabinofuranosylcytosine (Cyclo-C) Against Human CytomegalovirusCentral retinal vein occlusion after transplantation of the kidneyLong-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients.Utilisation du DHPG dans les infections graves a Cytomegalovirus apres transplantation renalePolymerase chain reaction assay for detection of human cytomegalovirusProgressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsGastrointestinal Complications in Patients with Acquired Immunodeficiency Syndrome: Review and the Amsterdam ExperienceCentral retinal vein occlusion after transplantation of the kidneyRapid Detection of Cytomegalovirus Pneumonia from Lung Lavage CellsLiver transplantation: An overviewIntravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression.Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).Treatment of Infections Associated with Human Immunodeficiency VirusCytomegalovirus infections and the skinHerpesvirus Infections (Cytomegalovirus, Herpes Simplex Virus, Varicella-Zoster Virus)Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitisRapid detection of cytomegalovirus by fluorescent monoclonal antibody staining and in situ DNA hybridization in a dram vial cell culture systemAntiviral AgentsIntravitreal Ganciclovir in the Treatment of AIDS-associated Cytomegalovirus RetinitisSerious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS) Clinical Findings, Diagnosis, and TreatmentMARK A. JACOBSON, M.D., JOHN MILLS, M.D.Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir).Ganciclovir—Have We Established Clinical Value in the Treatment of Cytomegalovirus Infections?RICHARD J. WHITLEY, M.D.La chimiothérapie des infections a cytomégalovirusHerpesviridae: CytomegalovirusTherapy and Prevention of Cytomegalovirus InfectionsInfection in the Cardiac Transplant PatientCentral Nervous System Infections in the Compromised HostNew Analogues to Acyclovir with Increased Potency to Herpes VirusesZytomegalievirusinfektion als Ursache von DarmperforationenRecent Advances in the Search for Selective Antiviral AgentsDrugs Five Years Later: AcyclovirDAVID I. DORSKY, M.D., Ph.D., CLYDE S. CRUMPACKER, M.D.Antiviral AgentsBone Marrow Transplantation: Its Biology and Role as Treatment for Acute and Chronic LeukemiasGanciclovir HepatotoxicityTreatment of CMV retinitis in an AIDS patient.Determination of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in biological fluids by reversed-phase high pressure liquid chromatographyDetecção de anticorpos IgM nas infecções primárias e secundárias pelo citomegalovírus em pacientes submetidos a transplante renalHepatic disease in patients with the acquired immune deficiency syndrome (AIDS)Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirusNouvelle approche de traitement des infections a cytomegalovirus apres greffe de moelle osseuse allogeniqueOphthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective study.Cytomegalovirus Pneumonitis in Patients with AIDSTreatment of Cytomegalovirus Retinopathy with GanciclovirTreatment of Cytomegalovirus Retinitis with GanciclovirCombined Short- and Long-term Therapy for the Treatment of Cytomegalovirus Retinitis Using Ganciclovir (BW B759U)Acquired Immunodeficiency Syndrome (AIDS)Developmental Therapeutics and the Acquired Immunodeficiency SyndromeVINCENT T. DEVITA Jr., M.D., SAMUEL BRODER, M. D., ANTHONY S. FAUCI, M.D., JOSEPH A. KOVACS, M.D., BRUCE A. CHABNER, M.D.Prevalence, Pathophysiology, and Treatment of Rhegmatogenous Retinal Detachment in Treated Cytomegalovirus RetinitisCytomegalovirus Retinitis and Response to Therapy with GanciclovirPathologic Features of Cytomegalovirus Retinopathy after Treatment with the Antiviral Agent GanciclovirEffect of combinations of difluoromethylornithine (DFMO) and 9[(1,3-dihydroxy-2-propoxy) methyl]guanine (DHPG) on human cytomegalovirusIn vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovirCytomegalovirus Retinitis in Rheumatic Disease: A Case ReportInhibition of Viral Polyamine BiosynthesisInfectious Diseases and the EyeUse of Intravitreal Ganciclovir (Dihydroxy Propoxymethyl Guanine) for Cytomegalovirus Retinitis in a Patient With AIDSChapter 15 Antiviral AgentsMiscellaneous antibacterial and antiviral drugsAnti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in rabbit corneaEffect of antiviral agents on replication of herpes simplex virus type 1 in brain culturesDrug Information Analysis ServiceTreatment of Cytomegalovirus Optic Neuritis With Dihydroxy Propoxymethyl GuanineA novel selective broad-spectrum anti-DNA virus agentManagement of infectious complications in acquired immunodeficiency syndromeTREATMENT OF CYTOMEGALOVIRUS PNEUMONITIS AFTER BONE MARROW TRANSPLANTATION WITH 9-[2-HYDROXY-1-(HYDROXYMETHYL) ETHOXYMETHYL] GUANINEComplications of the Acquired Immunodeficiency SyndromeB. CLOTET, M.D., M. GRIFOL, M.D., J. BOIX, M.D., J. JUNCA, M.D., M. FOZ, M.D., M. RIBAS, M.D.Breakthrough of Cytomegalovirus Infection Despite 9-(1,3-Dihydroxy-2-propoxymethyl)guanine TherapyMICHAEL C. BACH, M.D.Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesEffect of 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine on Serious Cytomegalovirus Disease in Eight Immunosuppressed Homosexual MenHENRY MASUR, M.D., H. CLIFFORD LANE, M.D., ALAN PALESTINE, M.D., PHILLIP D. SMITH, M.D., JODY MANISCHEWITZ, M.D., GARTH STEVENS, M.D., LESLIE FUJIKAWA, M.D., ABE M. MACHER, M.D., ROBERT NUSSENBLATT, M.D., BARBARA BAIRD, R.N., MARGARET MEGILL, R.N., ALEC WITTEK, M.D., GERALD V. QUINNAN, M.D., JOSEPH E. PARRILLO, M.D., ALAIN H. ROOK, M.D., LAWRENCE J. ERON, M.D., DONALD M. PORETZ, M.D., ROBIN I. GOLDENBERG, M.D., ANTHONY S. FAUCI, M.D., EDWARD P. GELMANN, M.D.Prophylactic use of immunoglobulin in bone marrow transplantationFoscarnet for Cytomegalovirus RetinitisD. R. J. SINGER, M.R.C.P., T. J. FALLON, M.B., Ch.B., W. E. SCHULENBURG, F.R.C.S., G. WILLIAMS, F.R.C.S., J. COHEN, M.SC., M.R.C.P.Chemotherapy of herpesvirus infections: Present successes and future hopes 1 September 1985Volume 103, Issue 3Page: 381-382KeywordsAIDSCytomegalovirus infectionMortalityNucleosidesPatientsPneumocystis carinii pneumoniaPneumonitisResearch laboratoriesRetinitisVirology Issue Published: 1 September 1985 PDF downloadLoading ...